ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Efficacy and Safety Results for Pembrolizumab in Previously Treated Gastric Cancer

Charles S. Fuchs, MD, MPH
Published Online:3:31 PM, Tue June 13, 2017

Charles S. Fuchs, MD, MPH, professor of Medicine, director, Yale Cancer Center, and physician-in-chief, Smilow Cancer Hospital, discusses efficacy and safety results for pembrolizumab (Keytruda) monotherapy in patients with previously treated advanced gastric cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.